Popular Articles

NICE Acknowledge Alzheimer's Model Faulty, But Do Not Plan To Change Reccomendations, UK
Eisai Limited, the licence holder of Aricept® (donepezil hydrochloride) and Pfizer Limited, its co-promotion partner, have been notified by the National Institute for Health and Clinical Excellence (NICE) of their decision to continue to deny vulnerable patients the use of anti-cholinergic medicines in the treatment of mild Alzheimer"s disease.

Osiris Therapeutics Reports Interim Data For COPD Stem Cell Study
Therapeutics, Inc. (NASDAQ:OSIR) announced six-month interim data from a Phase II clinical trial evaluating Prochymal, the Company"s proprietary formulation of adult mesenchymal stem cells, for the treatment of chronic obstructive pulmonary disease (COPD). Sixty-two patients were enrolled and are being followed for two years in the placebo-controlled study. At the six-month time-point, the data revealed several important findings.
News of the day
Anaphylaxis Canada Launches New Strategy To Help Keep More Than 250,000 Children And Young Adults With Severe Food Allergies Safe
Anaphylaxis Canada is responding to the growing public health challenge of keeping teens and young adults with potentially life-threatening food allergies safe by creating a number of interactive tools including a groundbreaking new website, http://www.whyriskit.ca, an online "Reaction Registry" and radio podcasts. These tools are part of a comprehensive new strategy to help allergic youth manage risky situations by reaching out to them in forums in which they are comfortable.
Mental Health

Howard County Pharmacy Owner Indicted For Health Care Fraud

A federal grand jury yesterday indicted Pamela Arrey, age 48, of Glenelg, Maryland, for health care fraud and aggravated identity theft, announced United States Attorney for the District of Maryland Rod J. Rosenstein. According to the 13 count indictment, Arrey owned and operated two pharmacies trading as the Medicine Shoppe, on Liberty Road and Reisterstown Road in Baltimore. From January 2003 to July 2008, Arrey allegedly claimed reimbursement from health care benefit programs for purported "refills" of prescriptions which patients had never requested and for which no prescription drugs were ever dispensed to customers. The indictment seeks forfeiture of property obtained by Arrey as a result of the scheme, including $350,000 and residential property located in Glenelg, Maryland. The indictment also alleges that Arrey used the identity of patients to carry out the health care fraud scheme. Arrey faces a maximum sentence of 10 years in prison for each of the 12 counts of health care fraud and a mandatory minimum of two years in prison consecutive to any other sentence for aggravated identity theft. No court appearance has been scheduled. An indictment is not a finding of guilt. An individual charged by indictment is presumed innocent unless and until proven guilty at some later criminal proceedings. United States Attorney Rod J. Rosenstein thanked the Department of Health and Human Services - Office of Inspector General and the Food and Drug Administration - Office of Criminal Investigations for their investigative work. Mr. Rosenstein commended Assistant United States Attorneys Sandra Wilkinson and Tonya Kelly Kowitz, who are prosecuting the case. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):